Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Gilead Sciences Inc. (NASDAQ:GILD) is an American biopharmaceutical company that researches, develops, and sells innovative medicines for life-threatening diseases, focusing on HIV/AIDS, viral hepatitis, cancer, COVID-19, and inflammation. It will report its Q3 2025 earnings on Nov. 5. Wall Street analysts expect the company to post EPS of $2.15, up from$2.02 in the prior-year period. According to data fr ...